▼
Allegations Only · No Settlement Yet
This article describes complaints filed by government agencies and private plaintiffs. The statements below are unproven
allegations. Hims & Hers Health, Inc. has not been found liable, there is no certified class, and
nothing to claim at this time. This page is informational. It is not legal advice.
On July 29, 2026, the Federal Trade Commission sued Hims & Hers Health, Inc., the telehealth company behind Hims.com and ForHers.com, in federal court in San Francisco. Los Angeles County, suing on behalf of the People of California, and Utah’s Division of Consumer Protection joined the case, Federal Trade Commission v. Hims & Hers Health, Inc., No. 3:26-cv-07871. It accuses Hims of charging consumers for prescription subscriptions they did not knowingly agree to, making cancellation difficult, and sharing health information with advertising platforms despite promising privacy.
A day later, on July 30, two users filed a proposed class action, Doe v. Hims & Hers Health, Inc., No. 3:26-cv-07941, in the same court. It focuses on the data sharing and seeks damages for people whose information was sent to third parties. A shareholder suit over the stock drop that followed the FTC announcement was filed on September 1.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
Status
Complaints Filed
FTC case filed July 29, 2026 · three consumer class actions filed July 30 – September 1, 2026 · no class certified
What Is Alleged
Surprise subscription charges, hard cancellations, health data shared with advertisers
Hims has not been found liable for any of it
Can I Claim?
No — nothing to claim yet
Hims sells its prescription treatments, for conditions including hair loss, sexual health, weight loss and mental health, as subscriptions. To get one, a consumer fills out an online medical intake form for a provider to review. The FTC alleges that Hims’ ads and intake forms told people they would get a free consultation and would “only be charged if prescribed,” leaving them to believe they could talk with a provider before deciding on treatment.
According to the complaint, Hims instead charged consumers and enrolled them in a subscription almost immediately after receiving the intake form, as soon as a provider recommended a treatment, giving them virtually no chance to review or turn down that treatment. The FTC says this happened to hundreds of thousands of consumers.
The complaint also alleges Hims did not clearly tell subscribers when refill charges would hit, so people missed the window to avoid refills they did not want, and that for years Hims made it hard to cancel. It says Hims did not add an online cancellation flow to its websites until April 2023, did not add it to its mobile apps, designed it to be hard to find and complete, and knew of the FTC’s scrutiny of its subscription practices by late 2023, when the agency sent it a civil investigative demand.
Hims advertised a “100% online, private, and secure” process and, until at least August 2023, told website visitors that medical records and sensitive information were accessed only by the providers managing their care, according to the FTC. The agency alleges that through at least May 2024, Hims used tracking pixels and similar tools that sent consumers’ health information to advertising platforms including Meta and Snap without their consent, and that it placed pixels from Google, Microsoft, Pinterest, Criteo and others on its website.
The Doe class action builds on those allegations. It says information users entered during the medical intake process, including answers about conditions and medications, was shared with Meta, Google, Snap and the analytics company Amplitude, along with other companies whose tracking code was on the Hims platform, together with identifiers that could link the data to specific people. The plaintiffs say the companies receiving the data used it for their own advertising purposes.
This is a separate matter from the Hims & Hers data breach lawsuit, which concerns a security incident rather than the company’s own tracking tools.
The FTC brings claims under Section 5 of the FTC Act and the Restore Online Shoppers’ Confidence Act, the federal law on online subscriptions, and asks for a court order changing Hims’ practices, monetary relief including restitution, and civil penalties. Los Angeles County brings claims under California’s Unfair Competition Law and False Advertising Law, and Utah under its Consumer Sales Practices Act.
The Doe complaint proposes a nationwide class of people in the United States who used the Hims & Hers platform and whose communications or data were shared with third parties, plus a California class. Its 13 claims include violations of the federal Electronic Communications Privacy Act, the California Confidentiality of Medical Information Act and the California Invasion of Privacy Act, along with invasion of privacy and unjust enrichment. The case was filed by Lowey Dannenberg, P.C. and Schubert Jonckheer & Kolbe LLP.
Two more proposed class actions followed. On August 14, 2026, seven Hims and Hers customers from several states filed Pearson v. Hims & Hers Health, Inc., No. 3:26-cv-08470, in the same San Francisco court, through the same law firms as Doe. It is the only one of the customer cases that takes on both issues. It proposes a nationwide privacy class of people whose information was shared with advertising and analytics companies, and a nationwide subscription class of people who paid for a Hims or Hers subscription and were misled by its marketing and cancellation practices, plus matching California subclasses. Its claims track Doe’s privacy claims and add California’s False Advertising Law, negligence per se and claims over the subscription practices the FTC described.
On September 1, 2026, a Florida resident filed Holbrook v. Hims & Hers Health, Inc., No. 3:26-cv-02286, in the U.S. District Court for the Middle District of Florida in Jacksonville. It proposes a class of Florida residents who visited Hims.com and whose communications were intercepted by third-party tracking tools. The complaint alleges that answers visitors gave to health questions, including on a symptom calculator and quizzes that require no account, were sent to Amplitude as they were selected, before any consent prompt, and that pages about specific conditions were reported to Meta, Snap, Reddit, Microsoft, Pinterest, Google and The Trade Desk. It claims violations of the Florida Security of Communications Act, which provides statutory damages of the greater of $100 a day or $1,000, along with breach of confidence, unjust enrichment and Florida’s Deceptive and Unfair Trade Practices Act.
Hims shares fell $4.32, or 14.73%, to close at $25.00 on July 29, 2026, the day the FTC announced its case, according to a securities class action filed September 1, Velanki v. Hims & Hers Health, Inc., No. 3:26-cv-09313. That suit, on behalf of people who bought Hims securities between August 4, 2025 and July 29, 2026, alleges the company and two executives failed to disclose the practices the FTC described. It is a separate case for investors, not for Hims customers.
None of the cases has reached a ruling on the merits, and Hims has not been found to have broken any law. In the FTC case, the court could eventually order refunds, but only through a judgment or settlement. In the customer cases, a court would first have to decide motions on the complaints and then whether to certify any class. Doe and Pearson, filed by the same lawyers in the same court over overlapping conduct, are the kind of cases courts often combine. OpenClassActions.com will update this page as the cases develop.
What is the FTC suing Hims & Hers for?
The FTC, joined by Los Angeles County on behalf of the People of California and Utah’s Division of Consumer Protection, alleges Hims charged consumers and enrolled them in prescription subscriptions almost immediately after they submitted an intake form, failed to clearly disclose refill charge dates, made cancelling difficult, and shared health information with advertising platforms such as Meta and Snap despite promising privacy. Hims has not been found liable.
Is there a Hims & Hers class action settlement?
No. As of October 18, 2026 the FTC case and the consumer class actions are at the complaint stage. There is no settlement, no fund and no claim form, and no class has been certified.
Who would be in the Hims & Hers privacy class action?
The proposed class in Doe v. Hims & Hers Health covers people in the United States who used the Hims & Hers websites or apps and whose communications or data were shared with third parties, including advertising and analytics companies, with a separate California class. A court has not certified either class.
Is there a Hims & Hers class action over subscription charges?
Yes. Pearson v. Hims & Hers Health, filed August 14, 2026 in the Northern District of California, proposes a nationwide class of people who paid for a Hims or Hers subscription and were misled by its marketing and cancellation practices, alongside a privacy class. No class has been certified, and there is nothing to claim yet.
Is this the same as the Hims & Hers data breach lawsuit?
No. The cases on this page are about subscription billing and tracking technology that allegedly sent health information to advertisers. The Hims & Hers data breach lawsuit is a separate case over a security incident.
Can the FTC case lead to refunds?
The FTC’s complaint asks the court for monetary relief, including restitution, along with civil penalties and an order changing Hims’ practices. Any refunds would depend on a court judgment or a settlement, and none has been announced.
- Federal Trade Commission v. Hims & Hers Health, Inc., No. 3:26-cv-07871 (N.D. Cal.) — docket and complaint (CourtListener)
- Doe v. Hims & Hers Health, Inc., No. 3:26-cv-07941 (N.D. Cal.) — docket and class action complaint (CourtListener)
- Pearson v. Hims & Hers Health, Inc., No. 3:26-cv-08470 (N.D. Cal.) — docket and class action complaint (CourtListener)
- Holbrook v. Hims & Hers Health, Inc., No. 3:26-cv-02286 (M.D. Fla.) — docket and class action complaint (CourtListener)
- Velanki v. Hims & Hers Health, Inc., No. 3:26-cv-09313 (N.D. Cal.) — securities class action docket (CourtListener)
For more class actions keep scrolling below.
Status
Complaints Filed
Case Title
Doe v. Hims & Hers Health, Inc.
Case Number
3:26-cv-07941
Court
U.S. District Court, Northern District of California
Date Filed
July 30, 2026
Related Case
FTC v. Hims & Hers Health, Inc., No. 3:26-cv-07871 (filed July 29, 2026)